NCT04798911

Brief Summary

Patients with some long-standing rheumatic diseases have stated that they want to be fully informed about their disease as they find it 'more scary not to know' about possible complications and consequences. Patients who have the information they want about their disease can fully take part in decisions about their own health creating a partnership with their doctor. Sjögren's Syndrome (SS) is a multi-system, long-standing rheumatic disease that has a negative impact on the daily life of patients. A common presentation of this disease is dry mouth, which can make talking, eating and swallowing more difficult. Project aims: We aim to ask patients with SS what information they think it would be important to know about SS. We plan to create a questionnaire that can be used by doctors to help deliver the right information to patients at hospital visits. Timescale: This project will take 36 months to complete. Clinical relevance: This questionnaire could be used in daily practice. It could help patients cope with their disease, take part in treatment decision and reduced uncertainty and distress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
243

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2018

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

March 5, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 15, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2021

Completed
Last Updated

October 12, 2021

Status Verified

March 1, 2021

Enrollment Period

2.8 years

First QC Date

March 5, 2021

Last Update Submit

October 11, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determine information needs of patients with SS and develop a new questionnaire

    Qualitative interviews with patients with SS Interview transcriptions and thematic analysis Adaptation of TINQ-BC for use in patients with SS - generation of relevant questions using themes from Phase 1 qualitative study (removal of those solely related to breast cancer from TINQ-BC) by the expert group Pilot testing of SS-INQ for content and readability will be done via focus groups whilst structural validity will be explored using factor analysis Testing of SS-INQ for reliability - internal consistency reliability and test-retest reliability

    3 years

Study Arms (2)

Observational - phase 1

Determination of Informational Needs (Months 0- 9) * Qualitative interviews with patients with SS * Interview transcriptions and thematic analysis

Other: Phase 1 Observational Interviews

Observational - phase 2

Phase 2 Development of the informational need instrument for SS \[SS-INQ\] (Months 9-32) * Adaptation of TINQ-BC for use in patients with SS - generation of relevant questions using themes from Phase 1 qualitative study (removal of those solely related to breast cancer from TINQ-BC) by the expert group * Pilot testing of SS-INQ for content and readability will be done via focus groups whilst structural validity will be explored using factor analysis * Testing of SS-INQ for reliability - internal consistency reliability and test-retest reliability

Other: Phase 1 Observational Interviews

Interventions

Qualitative interviews with patients with SS

Observational - phase 1Observational - phase 2

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Sjögren's Syndrome above 18 years old.

You may qualify if:

  • Adult patients with a diagnosis of primary SS as per the 2002 American-European Consensus Group (AECG) classification criteria, or
  • Adult patients with a diagnosis of primary SS as per the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria
  • Adults with the capacity to consent to their involvement in the study
  • Willingness to participate in focus groups
  • Fluency in the English language to allow participation in focus group discussion
  • Willingness to complete the newly developed questionnaire on at least on occasion

You may not qualify if:

  • Patients with SS who have developed lymphomatous chang

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College London Hospitals NHS Foundation Trust

London, NW1 2BU, United Kingdom

Location

MeSH Terms

Conditions

Sjogren's Syndrome

Condition Hierarchy (Ancestors)

Arthritis, RheumatoidArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesXerostomiaSalivary Gland DiseasesMouth DiseasesStomatognathic DiseasesDry Eye SyndromesLacrimal Apparatus DiseasesEye DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2021

First Posted

March 15, 2021

Study Start

October 12, 2018

Primary Completion

July 21, 2021

Study Completion

July 21, 2021

Last Updated

October 12, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations